New Guidance from ACOG for Treatment of Women with Menopausal Symptoms

Recommendations about traditional hormone therapy, nonhormonal strategies, and recently approved treatments

Sponsoring Organization: American College of Obstetricians and Gynecologists (ACOG)

Target Population: Women's healthcare providers

Background and Objective

Despite much new data, management of menopausal symptoms remains controversial. Now, ACOG reviews conventional systemic and vaginal hormone therapy (HT), details recently approved treatments, and provides information about nonhormonal strategies.

Key Recommendations

Management of Vasomotor Symptoms (VMS)

Systemic HT (including oral and transdermal routes), alone or combined with progestin, is the most effective therapy for menopausal VMS.
Although less effective than standard-dose systemic HT, lower-dose HT regimens are associated with more-favorable adverse effect profiles.
Systemic estrogen…

Reviewing Author

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health